- Home
- BRTX vs IBG Comparison
BRTX vs IBG Comparison
Compare BRTX & IBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- IBG
- Stock Information
- Founded
- BRTX 1997
- IBG 2018
- Country
- BRTX United States
- IBG Australia
- Employees
- BRTX N/A
- IBG N/A
- Industry
- BRTX Managed Health Care
- IBG Beverages (Production/Distribution)
- Sector
- BRTX Health Care
- IBG Consumer Staples
- Exchange
- BRTX Nasdaq
- IBG Nasdaq
- Market Cap
- BRTX 11.3M
- IBG 9.6M
- IPO Year
- BRTX N/A
- IBG 2024
- Fundamental
- Price
- BRTX $1.97
- IBG $0.94
- Analyst Decision
- BRTX Strong Buy
- IBG Strong Buy
- Analyst Count
- BRTX 1
- IBG 1
- Target Price
- BRTX $18.00
- IBG N/A
- AVG Volume (30 Days)
- BRTX 50.3K
- IBG 185.0K
- Earning Date
- BRTX 11-12-2024
- IBG 02-15-2025
- Dividend Yield
- BRTX N/A
- IBG N/A
- EPS Growth
- BRTX N/A
- IBG N/A
- EPS
- BRTX N/A
- IBG N/A
- Revenue
- BRTX $377,000.00
- IBG $3,147,763.00
- Revenue This Year
- BRTX $482.76
- IBG N/A
- Revenue Next Year
- BRTX $212.24
- IBG N/A
- P/E Ratio
- BRTX N/A
- IBG N/A
- Revenue Growth
- BRTX 189.55
- IBG N/A
- 52 Week Low
- BRTX $1.03
- IBG $0.60
- 52 Week High
- BRTX $3.67
- IBG $3.35
- Technical
- Relative Strength Index (RSI)
- BRTX 66.37
- IBG N/A
- Support Level
- BRTX $1.75
- IBG N/A
- Resistance Level
- BRTX $2.12
- IBG N/A
- Average True Range (ATR)
- BRTX 0.16
- IBG 0.00
- MACD
- BRTX 0.05
- IBG 0.00
- Stochastic Oscillator
- BRTX 79.47
- IBG 0.00
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter and retailer of a growing beverage portfolio of 60 formulations across 13 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands.